Neurogenesis by modulating angiotensin
US7858611B2 · kind B2 · utility
8Cited by
28References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2007 |
| Grant date | Dec 28, 2010 |
| Priority date | — |
| Expiry date | May 13, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The invention includes compositions and methods based on modulation angiotensin activity to stimulate or activate the formation of new nerve cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.